Reckitt Benckiser Healthcare (UK) Ltd.
🇬🇧United Kingdom
Clinical Trials
17
Active:14
Completed:2
Trial Phases
3 Phases
Phase 1:4
Phase 2:1
Phase 3:2
Drug Approvals
85
EMC:83
NMPA:2
Drug Approvals
Buprenorphine Hydrochloride and Naloxone Hydrochloride Sublingual Tablets
- Product Name
- 丁丙诺啡纳洛酮舌下片
- Approval Number
- H20180055
- Approval Date
- Sep 11, 2018
NMPA
Buprenorphine Hydrochloride and Naloxone Hydrochloride Sublingual Tablets
- Product Name
- 丁丙诺啡纳洛酮舌下片
- Approval Number
- H20180056
- Approval Date
- Sep 11, 2018
NMPA
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
Phase 1
4 (57.1%)Phase 3
2 (28.6%)Phase 2
1 (14.3%)No trials found
News
No news found